This week's artwork was donated by Gavin, a pediatric cancer patient who received treatment at The Children's Hospital of Philadelphia . The proportion of patients treated by permanent brachytherapy has been increasing rapidly in the past few years due to relatively low morbidity, good 10-year outcome, and better public awareness. The ABS recommends that dosimetric planning of the implant be carried out for all patients before seed insertion. 103Pd are 144Gy and 115-120Gy, respectively when brachytherapy is used as monotherapy. The ABS has no preference of one radionuclide over the other.
Postoperative dosimetry is recommended for all patients using various techniques.
The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, you should consult your health care provider.